Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Drug Targets|April 29, 2020
New Anti-VEGF Drugs in OphthalmologyClaudio Campa
Annual Review of Medicine|October 21, 2006
Targeting VEGF-A to treat cancer and age-related macular degenerationNapoleone Ferrara, Robert D Mass, Claudio Campa, et al.
Current Drug Targets|June 16, 2015
Anti-VEGF Therapy for Retinal Vein OcclusionsClaudio Campa, Giuseppe Alivernini, Elena Bolletta, et al.
European Journal of Ophthalmology|April 24, 2020
A novel mutation of BEST1 gene in Best diseaseClaudio Campa, Francesco Parmeggiani, Rossella Spena, et al.
Current Eye Research|November 21, 2007
Increased retinal blood flow in patients with active Graves' ophthalmopathyPaolo Perri, Claudio Campa, Ciro Costagliola, et al.
American Journal of Ophthalmology|July 29, 2014
Fundus autofluorescence patterns in Best vitelliform macular dystrophyMaurizio Battaglia Parodi, Pierluigi Iacono, Claudio Campa, et al.
Investigative Ophthalmology & Visual Science|March 11, 2008
Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changesClaudio Campa, Ian Kasman, Weilan Ye, et al.
Current Eye Research|June 24, 2008
Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprostCiro Costagliola, Claudio Campa, Paolo Perri, et al.
Pageof 3